|
1
|
Scheltens P, De Strooper B, Kivipelto M,
Holstege H, Chételat G, Teunissen CE, Cummings J and van der Flier
WM: Alzheimer's disease. Lancet. 397:1577–1590. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vejandla B, Savani S, Appalaneni R,
Veeravalli RS and Gude SS: Alzheimer's disease: The past, present,
and future of a globally progressive disease. Cureus.
16:e517052024.PubMed/NCBI
|
|
3
|
Zhang Q, Deng Y, Xue M, Ni Z, Luo G and
Tian K: Global trends in Alzheimer's disease and other dementias in
adults aged 55 and above (1992-2021): An age-period-cohort analysis
based on the GBD 2021. PLoS One. 20:e03312042025. View Article : Google Scholar :
|
|
4
|
Nasb M, Tao W and Chen N: Alzheimer's
disease puzzle: Delving into pathogenesis hypotheses. Aging Dis.
15:43–73. 2024.
|
|
5
|
Varadharajan A, Davis AD, Ghosh A, Jagtap
T, Xavier A, Menon AJ, Roy D, Gandhi S and Gregor T: Guidelines for
pharmacotherapy in Alzheimer's disease-a primer on FDA-approved
drugs. J Neurosci Rural Pract. 14:566–573. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Verma A, Kumar Waiker D, Bhardwaj B, Saraf
P and Shrivastava SK: The molecular mechanism, targets, and novel
molecules in the treatment of Alzheimer's disease. Bioorg Chem.
119:1055622022. View Article : Google Scholar
|
|
7
|
Cummings JL, Osse AML and Kinney JW:
Alzheimer's disease: Novel targets and investigational drugs for
disease modification. Drugs. 83:1387–1408. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo S, Wang H and Yin Y: Microglia
polarization from M1 to M2 in neurodegenerative diseases. Front
Aging Neurosci. 14:8153472022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cai Y, Liu J, Wang B, Sun M and Yang H:
Microglia in the Neuroinflammatory pathogenesis of Alzheimer's
disease and related therapeutic targets. Front Immunol.
13:8563762022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li S, Wang Y, Li J, Deng L and Dong Y:
Effect of galectin-1 on classical microglial activation,
neuroinflammation, and neuronal damage in rats exposed to amyloid-β
peptide. Basic Clin Neurosci J. 17:275–284. 2026. View Article : Google Scholar
|
|
11
|
Ahremenko E, Andreev A, Apushkin D and
Korkotian E: Glial cells in the early stages of neurodegeneration:
Pathogenesis and therapeutic targets. Int J Mol Sci. 26:119952025.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang X, Wang J, Jia X, Yang Y, Fang Y,
Ying X, Li H, Zhang M, Wei J and Pan Y: Microglial polarization in
Alzheimer's disease: Mechanisms, implications, and therapeutic
opportunities. J Alzheimers Dis. 104:3–13. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hachmann J and Salvesen GS: The
paracaspase MALT1. Biochimie. 122:324–338. 2016. View Article : Google Scholar
|
|
14
|
Afonina IS, Elton L, Carpentier I and
Beyaert R: MALT1-a universal soldier: Multiple strategies to ensure
NF-κB activation and target gene expression. FEBS J. 282:3286–3297.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang YY, Peng J and Luo XJ:
Post-translational modification of MALT1 and its role in B cell-
and T cell-related diseases. Biochem Pharmacol. 198:1149772022.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
O'Neill TJ, Tofaute MJ and Krappmann D:
Function and targeting of MALT1 paracaspase in cancer. Cancer Treat
Rev. 117:1025682023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hailfinger S and Schulze-Osthoff K: The
paracaspase MALT1 in psoriasis. Biol Chem. 402:1583–1589. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu HY and Turvey SE: Human MALT1
deficiency and predisposition to infections. Curr Opin Immunol.
72:1–12. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mempel TR and Krappmann D: Combining
precision oncology and immunotherapy by targeting the MALT1
protease. J Immunother Cancer. 10:e0054422022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brvar M, O'Neill TJ, Plettenburg O and
Krappmann D: An updated patent review of MALT1 inhibitors
(2021-present). Expert Opin Ther Pat. 35:639–656. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen X, Zhang X, Lan L, Xu G, Li Y and
Huang S: MALT1 positively correlates with Th1 cells, Th17 cells,
and their secreted cytokines and also relates to disease risk,
severity, and prognosis of acute ischemic stroke. J Clin Lab Anal.
35:e239032021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rang X, Liu Y, Wang J, Wang Y, Xu C and Fu
J: Identification of multiple sclerosis-related genes regulated by
EBV-encoded microRNAs in B cells. Mult Scler Relat Disord.
59:1035632022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ruan Z, Li Y and Chen Y: HECTD3 promotes
NLRP3 inflammasome and pyroptosis to exacerbate diabetes-related
cognitive impairment by stabilising MALT1 to regulate JNK pathway.
Arch Physiol Biochem. 130:373–384. 2024. View Article : Google Scholar
|
|
24
|
Zhang S, Yan Y, Wang Y, Sun Z, Han C, Qian
X, Ren X, Feng Y, Cai J and Xia C: Inhibition of MALT1 alleviates
spinal ischemia/reperfusion injury-induced neuroinflammation by
modulating glial endoplasmic reticulum stress in rats. J Inflamm
Res. 14:4329–4345. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu LQ, Li MR, Liu XY, Peng D, Liu HR,
Zhang XJ, Luo XJ and Peng J: CARD11-BCL10-MALT1 complex-dependent
MALT1 activation facilitates myocardial oxidative stress in
doxorubicin-treated mice via enhancing k48-linked ubiquitination of
Nrf2. Antioxid Redox Signal. 42:115–132. 2025. View Article : Google Scholar
|
|
26
|
Lee JE, Bo F, Thuy NTT, Hong J, Lee JS,
Cho N and Yoo HM: Anticancer activity of lesbicoumestan in jurkat
cells via inhibition of oxidative stress-mediated apoptosis and
MALT1 protease. Molecules. 26:1852021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Oriquat G, Hamed Ahmed M, Al-Hasnaawei S,
Malathi H, Mishra S, Nanda A, Arora V and Chauhan AS: Bridging
neuroinflammation, oxidative stress, and neurogenesis: Aromatic
turmerone as a multifunctional modulator via NF-κB and Nrf2
pathways. Inflammopharmacology. 34:3973–3989. 2026. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Liu Z, Zhang M, Yu B and Ai F:
Mucosa-associated lymphoid tissue lymphoma translocation protein 1
exaggerates multiple organ injury, inflammation, and immune cell
imbalance by activating the NF-κB pathway in sepsis. Front
Microbiol. 14:11172852023. View Article : Google Scholar
|
|
29
|
Blalock EM, Geddes JW, Chen KC, Porter NM,
Markesbery WR and Landfield PW: Incipient Alzheimer's disease:
Microarray correlation analyses reveal major transcriptional and
tumor suppressor responses. Proc Natl Acad Sci USA. 101:2173–2178.
2004. View Article : Google Scholar :
|
|
30
|
Mathys H, Davila-Velderrain J, Peng Z, Gao
F, Mohammadi S, Young JZ, Menon M, He L, Abdurrob F, Jiang X, et
al: Single-cell transcriptomic analysis of Alzheimer's disease.
Nature. 570:332–337. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Demeyer A, Staal J and Beyaert R:
Targeting MALT1 proteolytic activity in immunity, inflammation and
disease: Good or bad? Trends Mol Med. 22:135–150. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun E, Motolani A, Campos L and Lu T: The
pivotal role of NF-kB in the pathogenesis and therapeutics of
Alzheimer's disease. Int J Mol Sci. 23:89722022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Verma Y, Sachdeva H, Kalra S, Kumar P and
Singh G: Unveiling the complex role of NF-κB in Alzheimer's
disease: Insights into brain inflammation and potential therapeutic
targets. Georgian Med News. 133–141. 2023.
|
|
34
|
Zhao KP, Wang XY, Shao MQ, He CY and Yuan
FQ: Silencing of long noncoding RNA X-inactive specific transcript
alleviates Aβ1-42-induced microglia-mediated neurotoxicity by
shifting microglial M1/M2 polarization. Int J Immunopathol
Pharmacol. 37:39463202311849882023. View Article : Google Scholar
|
|
35
|
Cui ZQ, Hu XY, Yang T, Guan JW, Gu Y, Li
HY, Zhang HY, Xiao QH and Sun XH: TMEM16F may be a new therapeutic
target for Alzheimer's disease. Neural Regen Res. 18:643–651. 2023.
View Article : Google Scholar
|
|
36
|
Polini B, Ricardi C, Bertolini A,
Carnicelli V, Rutigliano G, Saponaro F, Zucchi R and Chiellini G:
T1AM/TAAR1 system reduces inflammatory response and β-amyloid
toxicity in human microglial HMC3 cell line. Int J Mol Sci.
24:115692023. View Article : Google Scholar
|
|
37
|
Fontan L, Yang C, Kabaleeswaran V, Volpon
L, Osborne MJ, Beltran E, Garcia M, Cerchietti L, Shaknovich R,
Yang SN, et al: MALT1 small molecule inhibitors specifically
suppress ABC-DLBCL in vitro and in vivo. Cancer Cell. 22:812–824.
2012. View Article : Google Scholar
|
|
38
|
Ding J, Zhang Y and Xu M: Circular RNA
DLGAP4 inhibits ischemic stroke-induced microglia M1 polarization
and proinflammatory cytokine production, possibly through the NF-κB
pathway. Tohoku J Exp Med. 263:277–285. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang L, Li J, Yang Z, Wang S, Liu J, Luan
S and Tian G: Linkage of blood MALT1 with CD4+ T cell subset,
inflammation, lipid, and its potency as a biomarker for predicting
major adverse cardiovascular events in coronary heart disease
patients. Ann Clin Lab Sci. 53:507–515. 2023.PubMed/NCBI
|
|
40
|
Wang M, Huang L, Peng L, Yang Y, Mao J,
Zhu N and Wu B: MALT1 serves as a biomarker for estimating disease
risk of lupus nephritis: A prospective case-control study. Ann
Transl Med. 10:8742022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jiang VC, Liu Y, Lian J, Huang S, Jordan
A, Cai Q, Lin R, Yan F, McIntosh J, Li Y, et al: Cotargeting of BTK
and MALT1 overcomes resistance to BTK inhibitors in mantle cell
lymphoma. J Clin Invest. 133:e1656942023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lu T, Connolly PJ, Philippar U, Sun W,
Cummings MD, Barbay K, Gys L, Van Nuffel L, Austin N, Bekkers M, et
al: Discovery and optimization of a series of small-molecule
allosteric inhibitors of MALT1 protease. Bioorg Med Chem Lett.
29:1267432019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Quancard J, Klein T, Fung SY, Renatus M,
Hughes N, Israël L, Priatel JJ, Kang S, Blank MA, Viner RI, et al:
An allosteric MALT1 inhibitor is a molecular corrector rescuing
function in an immunodeficient patient. Nat Chem Biol. 15:304–313.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wu G, Wang H, Zhou W, Zeng B, Mo W, Zhu K,
Liu R, Zhou J, Chen C and Chen H: Synthesis and structure-activity
relationship studies of MI-2 analogues as MALT1 inhibitors. Bioorg
Med Chem. 26:3321–3344. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wu C, Ge W and Wu Y: Mucosa-associated
lymphoid tissue lymphoma translocation protein 1 inhibitor, MI-2,
attenuates non-small cell lung cancer cell proliferation, migration
and invasion, and promotes apoptosis by suppressing the JNK/c-JUN
pathway. Oncol Lett. 28:4652024. View Article : Google Scholar
|
|
46
|
Nakamura Y, Igaki K, Komoike Y, Yokoyama K
and Tsuchimori N: Malt1 inactivation attenuates experimental
colitis through the regulation of Th17 and Th1/17 cells. Inflamm
Res. 68:223–230. 2019. View Article : Google Scholar
|
|
47
|
Qin H, Wu T, Liu J, Wang G, Fan L, Wang B
and Shen Y: MALT-1 inhibition attenuates the inflammatory response
of ankylosing spondylitis by targeting NF-κB activation. Injury.
52:1287–1293. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang H, Sun G, Li X, Fu Z, Guo C, Cao G,
Wang B, Wang Q, Yang S, Li D, et al: Inhibition of MALT1
paracaspase activity improves lesion recovery following spinal cord
injury. Sci Bull (Beijing). 64:1179–1194. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Si W, Li X, Jing B, Chang S, Zheng Y, Chen
Z, Zhao G and Zhang D: Stigmasterol regulates microglial M1/M2
polarization via the TLR4/NF-κB pathway to alleviate neuropathic
pain. Phytother Res. 38:265–279. 2024. View Article : Google Scholar
|
|
50
|
Wang XF, Wang F and Zhou G: MALT1 protease
regulates T-cell immunity via the mTOR pathway in oral lichen
planus. Inflammation. 47:939–957. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bhardwaj V, Kumari S, Dhapola R, Sharma P,
Beura SK, Singh SK, Vellingiri B and HariKrishnaReddy D: Shedding
light on microglial dysregulation in Alzheimer's disease: Exploring
molecular mechanisms and therapeutic avenues. Inflammopharmacology.
33:679–702. 2025. View Article : Google Scholar
|
|
52
|
Jurcău MC, Andronie-Cioara FL, Jurcău A,
Marcu F, Ţiț DM, Pașcalău N and Nistor-Cseppentö DC: The Link
between oxidative stress, mitochondrial dysfunction and
neuroinflammation in the pathophysiology of Alzheimer's disease:
Therapeutic implications and future perspectives. Antioxidants
(Basel). 11:21672022. View Article : Google Scholar
|
|
53
|
Li R, Jia H, Si M, Li X, Ma Z, Zhu Y, Sun
W, Zhu F and Luo S: Loureirin B protects against cerebral
ischemia/reperfusion injury through modulating M1/M2 microglial
polarization via STAT6/NF-kappaB signaling pathway. Eur J
Pharmacol. 953:1758602023. View Article : Google Scholar
|
|
54
|
Yao K and Zu HB: Microglial polarization:
Novel therapeutic mechanism against Alzheimer's disease.
Inflammopharmacology. 28:95–110. 2020. View Article : Google Scholar
|
|
55
|
Uddin MS, Hasana S, Ahmad J, Hossain MF,
Rahman MM, Behl T, Rauf A, Ahmad A, Hafeez A, Perveen A and Ashraf
GM: Anti-neuroinflammatory potential of polyphenols by inhibiting
NF-κB to halt Alzheimer's disease. Curr Pharm Des. 27:402–414.
2021. View Article : Google Scholar
|
|
56
|
Jin X, Liu MY, Zhang DF, Zhong X, Du K,
Qian P, Yao WF, Gao H and Wei MJ: Baicalin mitigates cognitive
impairment and protects neurons from microglia-mediated
neuroinflammation via suppressing NLRP3 inflammasomes and
TLR4/NF-κB signaling pathway. CNS Neurosci Ther. 25:575–590. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Li P, He Y, Yang Q, Guo H, Li N and Zhang
D: NEK7 inhibition attenuates Aβ42-induced cognitive
impairment by regulating TLR4/NF-κB and the NLRP3 inflammasome in
mice. J Clin Biochem Nutr. 73:145–153. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhang F, Zhong R, Li S, Fu Z, Cheng C, Cai
H and Le W: Acute hypoxia induced an imbalanced M1/M2 activation of
microglia through NF-κB signaling in Alzheimer's disease mice and
wild-type littermates. Front Aging Neurosci. 9:2822017. View Article : Google Scholar
|
|
59
|
Lei P, Li Z, Hua Q, Song P, Gao L, Zhou L
and Cai Q: Ursolic acid alleviates neuroinflammation after
intracerebral hemorrhage by mediating microglial pyroptosis via the
NF-κB/NLRP3/GSDMD pathway. Int J Mol Sci. 24:147712023. View Article : Google Scholar
|
|
60
|
Giridharan S and Srinivasan M: Mechanisms
of NF-κB p65 and strategies for therapeutic manipulation. J Inflamm
Res. 11:407–419. 2018. View Article : Google Scholar
|
|
61
|
Wang R, Qian Y, Zhou X, Xu H, Wang Y, Geng
Y, Wang T and Sha B: Single-cell sequencing and transcriptomic data
reveal that P65 activation significantly promotes
microglia-mediated neuroinflammation after ischemic stroke. Sci
Rep. 15:177602025. View Article : Google Scholar :
|
|
62
|
Atta AA, Ibrahim WW, Mohamed AF and
Abdelkader NF: Microglia polarization in nociplastic pain:
Mechanisms and perspectives. Inflammopharmacology. 31:1053–1067.
2023. View Article : Google Scholar : PubMed/NCBI
|
